Wilmington, DE, United States of America

Richard Eric Olson

This inventor holds 118 USPTO granted patents and 33 published patent applications, plus 1 CIPO patent and 28 EPO patents, primarily in T Cell Activators (CPC class C07D-). Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Squibb Pharma Company, E.i. Dupont De Nemours and Company. Active years: 1988-2025.

USPTO Granted Patents = 118 

% Patents Active = 87.3

 

 

Average Co-Inventor Count = 3.2

ph-index = 17

Forward Citations = 1,273(Granted Patents)

Forward Citations (Not Self Cited) = 911(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Townsend, MA (US) (1989)
  • Boylston, MA (US) (1997)
  • Corvallis, OR (US) (2003)
  • Rindge, NH (US) (1990 - 2007)
  • Wilmington, DE (US) (1988 - 2010)
  • Orange, CT (US) (2010 - 2022)
  • Wallingford, CT (US) (2021 - 2022)
  • Cambridge, MA (US) (2020 - 2024)

Company Filing History:

goldMedal44 out of 3,736 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal27 out of 234 
 
Bristol-Myers Squibb Pharma Company
 patents
bronzeMedal9 out of 16,339 
 
E.i. Dupont De Nemours and Company
 patents
4. 6 out of 97 
 
Albany Molecular Research, Inc.
 patents
5. 6 out of 206 
 
The Dupont Merck Pharmaceutical Company
 patents
6. 5 out of 2,297 
 
Digital Equipment Corporation
 patents
7. 5 out of 106 
 
Dupont Pharmaceuticals Company
 patents
8. 4 out of 46 
 
Roche Innovation Center Copenhagen A/s
 patents
9. 3 out of 10 
 
Bristol-Myers Squibb Pharma Corporation
 patents
10. 3 out of 27,658 
 
Hewlett-Packard Development Company, L.p.
 patents
11. 3 out of 5,020 
 
Hoffmann-La Roche Inc.
 patents
12. 3 out of 4,770 
 
Merck + Co., Inc.
 patents
13. 2 out of 15 
 
Dupont Pharmaceuticals, Inc.
 patents
14. 2 out of 180 
 
F. Hoffmann-La Roche Ag
 patents
15. 2 out of 1,205 
 
Scripps Research Institute
 patents
16. 1 out of 41 
 
Bristol Meyers Squibb Company
 patents
17. 1 out of 2,019 
 
Compaq Computer Corporation, Inc.
 patents
18. 1 out of 1 
 
E. I. Du Pont De Nemours and Cmopany
 patent
19. 4 out of 834,411 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
T Cell Activators
Antisense Oligonucleotides
Beta-Amyloid Reduction
Nicotinic Acetylcholine Receptor
Tau Expression Modulation
Phosphorus Compounds
Therapeutic Molecules
Selective NR2B Antagonists
Bicyclic Compounds
Tricyclic Compounds
Quinazolinyl Compounds
Piperazine Derivatives
118 patents (USPTO):Explore Patents

Title: The Innovative Journey of Richard Eric Olson

Introduction: Richard Eric Olson, a pioneering inventor based in Wilmington, DE (US), has made significant contributions to the field of technology through his inventive spirit and dedication to innovation.

Latest Patents: Richard Eric Olson holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights: With a background in engineering and a passion for problem-solving, Richard Eric Olson has successfully developed groundbreaking solutions that have improved efficiency and functionality across different industries. His innovative mindset has led to the creation of cutting-edge technologies that have garnered recognition worldwide.

Collaborations: Throughout his career, Richard Eric Olson has collaborated with leading research institutions, universities, and tech companies to further enhance his inventions and bring them to market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Richard Eric Olson's remarkable journey as an inventor showcases his commitment to pushing the boundaries of technology and creating solutions that have a lasting impact on society. His innovative spirit continues to inspire future generations of inventors to think outside the box and pursue their creative visions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…